401948-16-1

Basic information

• Product Name: 4-Piperidinecarboxaldehyde, 1-(trifluoroacetyl)- (9CI)
• Synonyms: 4-Piperidinecarboxaldehyde, 1-(trifluoroacetyl)- (9CI)
• CAS NO: 401948-16-1
• Molecular Formula: C8H10F3NO2
• Molecular Weight: 209.1657096
• Product Categories: ACETYLHALIDE
• Mol File: 401948-16-1.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-Piperidinecarboxaldehyde, 1-(trifluoroacetyl)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Piperidinecarboxaldehyde, 1-(trifluoroacetyl)- (9CI)(401948-16-1)
• EPA Substance Registry System: 4-Piperidinecarboxaldehyde, 1-(trifluoroacetyl)- (9CI)(401948-16-1)

Safety Data

• Hazardous Substances Data: 401948-16-1(Hazardous Substances Data)

Upstream product

• 6457-49-4 4-piperidinemethanol 
• 156459-82-4 N-trifluoroacetyl-4-(hydroxymethyl)piperidine 

Relevant articles and documents

Small Molecule Inhibitors of the BfrB-Bfd Interaction Decrease Pseudomonas aeruginosa Fitness and Potentiate Fluoroquinolone Activity

The iron storage protein bacterioferritin (BfrB) is central to bacterial iron homeostasis. The mobilization of iron from BfrB, which requires binding by a cognate ferredoxin (Bfd), is essential to the regulation of cytosolic iron levels in P. aeruginosa. This paper describes the structure-guided development of small molecule inhibitors of the BfrB-Bfd protein-protein interaction. The process was initiated by screening a fragment library and followed by obtaining the structure of a fragment hit bound to BfrB. The structural insights were used to develop a series of 4-(benzylamino)- A nd 4-((3-phenylpropyl)amino)-isoindoline-1,3-dione analogs that selectively bind BfrB at the Bfd binding site. Challenging P. aeruginosa cells with the 4-substituted isoindoline analogs revealed a dose-dependent growth phenotype. Further investigation determined that the analogs elicit a pyoverdin hyperproduction phenotype that is consistent with blockade of the BfrB-Bfd interaction and ensuing irreversible accumulation of iron in BfrB, with concomitant depletion of iron in the cytosol. The irreversible accumulation of iron in BfrB prompted by the 4-substituted isoindoline analogs was confirmed by visualization of BfrB-iron in P. aeruginosa cell lysates separated on native PAGE gels and stained for iron with Ferene S. Challenging P. aeruginosa cultures with a combination of commercial fluoroquinolone and our isoindoline analogs results in significantly lower cell survival relative to treatment with either antibiotic or analog alone. Collectively, these findings furnish proof of concept for the usefulness of small molecule probes designed to dysregulate bacterial iron homeostasis by targeting a protein-protein interaction pivotal for iron storage in the bacterial cell.

SMALL MOLECULE INHIBITORS OF THE BFRB:BFD INTERACTION

The present technology provides compounds of Formula I and related methods for treating a bacterial infection as well as methods for inhibiting interaction of a bacterioferritin and a bacterioferritin-associated ferredoxin.

CYCLOPROPYL-AMIDE COMPOUNDS AS DUAL LSD1/HDAC INHIBITORS

The present disclosure describes novel compounds of the general Formula (I), their analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites, and prodrugs thereof. These compounds can inhibit both LSD and HDAC and are useful as therpeautic or ameliorating agent for diseases that are involved in cellular growth such as malignant tumors, schizophrenia, Alzheimer's disease, parkinson's disease and the like.